Cue Biopharma's average Accounts Receivable for the
three
months ended in Dec. 2024 was $2.05 Mil. Cue Biopharma's Revenue for the
three
months ended in Dec. 2024 was $1.58 Mil.
Hence, Cue Biopharma's Days Sales Outstanding for the
three
months ended in Dec. 2024 was 118.61.
The historical rank and industry rank for Cue Biopharma's Days Sales Outstanding or its related term are showing as below:
CUE'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.94 Med: 69.02 Max: 469.08
Current: 71.07
During the past 10 years, Cue Biopharma's highest Days Sales Outstanding was 469.08. The lowest was 51.94. And the median was 69.02.
CUE's Days Sales Outstanding is ranked better than 51.24% of 847
companies
in the Biotechnology industry
Industry Median: 72.78
vs CUE: 71.07
Cue Biopharma's Days Sales Outstanding
increased
from Dec. 2023 (84.16) to Dec. 2024 (118.61).
Cue Biopharma Days Sales Outstanding Historical Data
The historical data trend for Cue Biopharma's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cue Biopharma's Days Sales Outstanding
For the Biotechnology subindustry, Cue Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cue Biopharma's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cue Biopharma's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cue Biopharma's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cue Biopharma (NAS:CUE) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Cue Biopharma Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Cue Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CUE has been successfully added to your 